Getting Bylvay (Odevixibat) Covered by Cigna in Virginia: Prior Authorization, Appeals, and State Protections
Answer Box: Fast Track to Bylvay Coverage
Getting Bylvay (odevixibat) covered by Cigna in Virginia requires three key steps: First, your specialist must submit a prior authorization request through Express Scripts/Accredo with complete medical necessity documentation. Second, if denied, file an internal appeal within 180 days citing Virginia's step therapy protections and medical exception criteria. Third, if still denied, request external review through Virginia's Bureau of Insurance within 120 days using Form 216-A.
Start today: Have your gastroenterologist or hepatologist call Cigna at 1-800-88-CIGNA to initiate the prior authorization process and confirm current submission requirements.
Table of Contents
- Why Virginia State Rules Matter
- Prior Authorization Requirements & Turnaround Standards
- Virginia Step Therapy Protections
- Medical Necessity Documentation
- Cigna Appeals Process in Virginia
- External Review Through Virginia Bureau of Insurance
- Common Denial Reasons & How to Overturn Them
- Practical Scripts for Patients and Providers
- Coverage Requirements at a Glance
- Frequently Asked Questions
Why Virginia State Rules Matter
Virginia's insurance regulations provide crucial protections that interact with Cigna's internal policies to benefit patients seeking Bylvay coverage. The state's step therapy reform law requires insurers to grant medical exceptions when specific criteria are met, while Virginia's external review process through the Bureau of Insurance offers an independent pathway to overturn wrongful denials.
For rare disease medications like Bylvay, these protections are especially important because they establish clear timelines and medical exception pathways that can override restrictive formulary policies. Virginia residents have additional recourse through the Managed Care Ombudsman at 1-877-310-6560, who can provide guidance on navigating complex specialty drug appeals.
Note: Self-funded employer plans may not be subject to all Virginia state protections, though many Virginia-based employers opt into the state's external review process.
Prior Authorization Requirements & Turnaround Standards
Cigna manages Bylvay through its specialty pharmacy network, typically Express Scripts/Accredo. The prior authorization process follows these timelines:
Standard Requests:
- Non-urgent: 72 hours for pharmacy drugs
- Urgent: 24 hours when clinical urgency is documented
- Automatic approval if Cigna doesn't respond within timeframes
Submission Methods:
- Electronic: EviCore by Evernorth (select "Pharmacy Drugs - Express Scripts Coverage")
- Portal: MyAccredoPatients.com for specialty medications
- Phone: 1-800-88-CIGNA for provider services
Required Documentation for Initial PA
Your prescribing specialist must include:
- Patient demographics with Cigna member ID
- Diagnosis confirmation (ICD-10 codes for PFIC or Alagille syndrome)
- Weight-based dosing calculations with clinical rationale
- Prior therapy attempts and outcomes
- Symptom severity assessment and quality of life impact
Virginia Step Therapy Protections
Virginia's step therapy law requires Cigna to grant exceptions within 72 hours (24 hours for urgent cases) when your provider demonstrates that:
- Contraindication exists: The required drug would likely cause harm
- Clinical ineffectiveness: The step therapy drug would be ineffective based on patient characteristics
- Prior trial and failure: Patient previously tried the required drug with lack of efficacy or adverse events
- Current therapeutic success: Patient is stable on the prescribed medication under current or previous coverage
Key Documentation Phrases:
- "Based on the patient's genetic confirmation of PFIC type [X], standard bile acid sequestrants are contraindicated due to..."
- "Previous trial of [medication] resulted in inadequate pruritus control as evidenced by..."
- "Patient's weight-based dosing requirements exceed standard quantity limits due to..."
Medical Necessity Documentation
Successful Bylvay appeals require comprehensive clinical justification. Your specialist should include:
Clinical History Requirements
- Age at symptom onset and current severity
- Objective pruritus scoring (if available)
- Impact on sleep, development, and quality of life
- Previous hospitalizations or complications
Diagnostic Confirmation
- Genetic testing results confirming PFIC subtype or Alagille syndrome
- Liver function tests and bile acid levels
- Histological findings from liver biopsy (if performed)
Treatment Rationale
- Specific mechanism of action for patient's condition
- Weight-based dosing calculations
- Expected clinical outcomes and monitoring plan
- Why alternative treatments are inappropriate
Clinician Corner: The Ipsen medical necessity guide provides templates that align with payer requirements and can strengthen your appeal documentation.
Cigna Appeals Process in Virginia
When Cigna denies Bylvay coverage, Virginia residents follow this appeals pathway:
Internal Appeals (First Level)
- Deadline: 180 days from denial notice
- Response time: 30 days for medical necessity appeals
- Submission: Cigna National Appeals Unit, P.O. Box 188011, Chattanooga, TN 37422
- Required elements: Member ID, claim number, medical necessity justification, supporting documentation
Expedited Appeals
- Timeline: 72 hours for urgent medical situations
- Criteria: Delay would seriously jeopardize health or ability to regain function
- Process: Call 1-800-88-CIGNA and state "expedited appeal request"
Peer-to-Peer Review
Medical necessity denials have an 80-85% overturn rate with peer-to-peer review. Your specialist can request direct physician-to-physician discussion with Cigna's medical reviewers to explain the clinical rationale for Bylvay.
External Review Through Virginia Bureau of Insurance
After exhausting Cigna's internal appeals, Virginia residents can request independent external review:
Filing Requirements
- Deadline: 120 days from final internal denial
- Form: Form 216-A External Review Request
- Cost: Free to consumers
- Contact: Virginia Bureau of Insurance at 1-877-310-6560
Review Process
- Standard timeline: 45 days for decision
- Expedited timeline: 72 hours for urgent cases
- Reviewer: Independent medical experts with relevant specialty knowledge
- Decision: Binding on Cigna if overturned
The Bureau randomly assigns cases to avoid conflicts of interest and ensures reviewers have appropriate expertise for rare genetic conditions like PFIC and Alagille syndrome.
Common Denial Reasons & How to Overturn Them
| Denial Reason | Appeal Strategy | Required Documentation |
|---|---|---|
| Age below threshold | Cite FDA approval for ≥3 months (PFIC) or ≥12 months (Alagille) | Birth certificate, diagnosis confirmation |
| Lack of specialist diagnosis | Emphasize pediatric gastroenterologist/hepatologist credentials | Provider CV, board certification |
| Off-label use for general cholestasis | Clarify specific FDA-approved indications | Genetic testing, diagnostic criteria |
| Quantity limits exceeded | Justify weight-based dosing calculations | Growth charts, dosing rationale |
| Step therapy requirement | Document contraindications or prior failures | Treatment history, adverse event records |
Practical Scripts for Patients and Providers
Patient Phone Script for Cigna
"Hello, I'm calling about prior authorization for Bylvay, generic name odevixibat, for my child with [PFIC/Alagille syndrome]. Our specialist submitted the request on [date]. Can you provide the status and any additional documentation needed? Our member ID is [number]."
Provider Peer-to-Peer Request
"I'm requesting peer-to-peer review for Bylvay coverage denial for a pediatric patient with genetically confirmed PFIC. The patient meets FDA approval criteria and has failed standard therapies. I can provide detailed clinical rationale and would like to discuss this case with your medical reviewer."
Appeal Letter Opening
"This appeal requests coverage for Bylvay (odevixibat) for [patient name], member ID [number], who has genetically confirmed [condition]. Under Virginia Code § 38.2-3407.9:05, this medication qualifies for step therapy exception because [specific criterion]. The following clinical evidence demonstrates medical necessity..."
Coverage Requirements at a Glance
| Requirement | PFIC Patients | Alagille Syndrome | Documentation Source |
|---|---|---|---|
| Minimum age | ≥3 months | ≥12 months | FDA label |
| Specialist diagnosis | Pediatric GI/hepatology | Pediatric GI/hepatology | Medical records |
| Genetic confirmation | PFIC subtype testing | Clinical or genetic diagnosis | Lab reports |
| Prior authorization | Required | Required | Cigna policy |
| Formulary status | Specialty tier | Specialty tier | Plan documents |
| Quantity limits | Weight-based dosing | Weight-based dosing | Clinical justification |
Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical documentation to create evidence-backed rebuttals. Their platform helps patients and providers navigate complex prior authorization requirements and build compelling cases for specialty medications like Bylvay.
Frequently Asked Questions
How long does Cigna prior authorization take for Bylvay in Virginia? Standard requests: 72 hours. Urgent requests: 24 hours. Cigna must auto-approve if they don't respond within these timeframes per their coverage policies.
What if Bylvay is non-formulary on my Cigna plan? Request a formulary exception through your prescriber. Virginia's step therapy protections apply, and you can appeal to external review if denied.
Can I request expedited appeals for Bylvay denials? Yes, if your doctor certifies that delays could seriously jeopardize health. Virginia allows expedited external review within 72 hours for urgent cases.
Does Virginia's step therapy law help with Bylvay coverage? Yes, Virginia requires medical exceptions when standard therapies are contraindicated, ineffective, or previously failed, which often applies to PFIC and Alagille syndrome patients.
What happens if my employer plan is self-funded? Self-funded plans may not follow all Virginia protections, but many Virginia employers opt into the state's external review process. Check with your HR department.
How much does Bylvay cost without insurance? Annual costs range from approximately $170,000 to $530,000 depending on weight-based dosing. Ipsen Cares offers patient assistance programs.
Can I get help with the appeals process? Yes, contact Virginia's Managed Care Ombudsman at 1-877-310-6560 for guidance, or consider working with Counterforce Health to develop evidence-backed appeal strategies.
What if Cigna requires step therapy for Bylvay? Document why standard bile acid therapies are inappropriate for your child's specific condition. Virginia law requires exceptions for contraindications or prior failures within 72 hours.
From our advocates: "We've seen families succeed by gathering comprehensive documentation before starting the appeals process. One key tip: ask your specialist to clearly state why standard therapies won't work for your child's specific genetic subtype. This medical exception language often resonates with reviewers and can expedite approvals."
Sources & Further Reading
- Virginia Step Therapy Law § 38.2-3407.9:05
- Virginia External Review Process
- Cigna Appeals and Grievances Guide
- Bylvay Medical Necessity Guide (Ipsen)
- Virginia Bureau of Insurance Consumer Services
- Express Scripts Prior Authorization
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage requirements. For personalized assistance with appeals, contact Virginia's consumer protection resources or professional advocacy services.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.